10-Q · 2026-11-09
TG Therapeutics, Inc. shares its Q3 results, showcasing growth and strategic initiatives in the pharmaceutical preparations sector.
| Name | TG THERAPEUTICS, INC. |
|---|---|
| CIK | 0001001316 |
| Tickers | TGTX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 363898269 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (212) 554-4484 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
TG Therapeutics, Inc. shares its Q3 results, showcasing growth and strategic initiatives in the pharmaceutical preparations sector.
TG Therapeutics boosts its 2026 revenue guidance to $1 billion following strong Q3 results, highlighting growth in its BRIUMVI product line.
1151 filing rows loaded from submissions recent; extra archives: CIK0001001316-submissions-001.json (150 filings, 1996-07-03 to 2003-03-08).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-09 | 10-Q | 10-Q | 0001628280-26-072257 | 001-32639 | 261536522 | 34 | 7573822 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-071870 | 001-32639 | 261533769 | 34 | 290435 | 1 | 1 |
| 2026-10-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003853 | 005-51051 | 261491718 | 34 | 11314 | |||
| 2026-09-14 | 4 | FORM 4 | 0001437749-26-030343 | 5524 | ||||||
| 2026-09-10 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-006866 | 001-32639 | 261371741 | 33 | 4602 | |||
| 2026-08-07 | 4 | FORM 4 | 0001437749-26-026608 | 8005 | ||||||
| 2026-08-05 | 10-Q | FORM 10-Q | 0001437749-26-025955 | 001-32639 | 261244582 | 34 | 7730823 | 1 | 1 | |
| 2026-08-03 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-025304 | 001-32639 | 261230439 | 34 | 360155 | 1 | 1 |
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020679 | 5953 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020677 | 5922 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020676 | 5927 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020675 | 6001 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0001437749-26-020673 | 5959 | ||||||
| 2026-06-12 | 8-K | FORM 8-K | 5.07 | 0001437749-26-020491 | 001-32639 | 261087312 | 34 | 180460 | 1 | 1 |
| 2026-06-03 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-26-019262 | 001-32639 | 261058932 | 34 | 228252 | 1 | 1 |
| 2026-05-27 | 8-K | FORM 8-K | 8.01,9.01 | 0001437749-26-018586 | 001-32639 | 261026776 | 34 | 213703 | 1 | 1 |
| 2026-05-06 | 10-Q | FORM 10-Q | 0001437749-26-015246 | 001-32639 | 26949519 | 34 | 8570114 | 1 | 1 | |
| 2026-05-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-015013 | 001-32639 | 26945813 | 34 | 307014 | 1 | 1 |
| 2026-04-30 | DEF 14A | FORM DEF 14A | 0001437749-26-014233 | 001-32639 | 26926160 | 34 | 3248262 | 1 | 1 | |
| 2026-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100121-26-000832 | 005-51051 | 26915464 | 34 | 7639 | |||
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-002442 | 005-51051 | 26804832 | 34 | 7458 | |||
| 2026-03-20 | 8-K | FORM 8-K | 1.01,2.03,9.01 | 0001437749-26-009253 | 001-32639 | 26778686 | 34 | 169155 | 1 | 1 |
| 2026-02-27 | 10-K | FORM 10-K | 0001437749-26-006133 | 001-32639 | 26701542 | 34 | 10096076 | 1 | 1 | |
| 2026-02-26 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-26-005733 | 001-32639 | 26681676 | 34 | 366650 | 1 | 1 |
| 2026-01-29 | 4 | FORM 4 | 0001437749-26-002439 | 6429 | ||||||
| 2026-01-13 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-26-001194 | 001-32639 | 26530367 | 34 | 215226 | 1 | 1 |
| 2026-01-09 | 4 | FORM 4 | 0001437749-26-001016 | 5265 | ||||||
| 2026-01-09 | 4 | FORM 4 | 0001437749-26-001015 | 4839 | ||||||
| 2025-11-25 | 4 | FORM 4 | 0001437749-25-036358 | 4909 | ||||||
| 2025-11-24 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007234 | 001-32639 | 251512866 | 33 | 4650 | |||
| 2025-11-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000093751-25-000636 | 005-51051 | 251464658 | 34 | 8287 | |||
| 2025-11-07 | 4 | FORM 4 | 0001437749-25-033888 | 6507 | ||||||
| 2025-11-05 | 10-Q | FORM 10-Q | 0001437749-25-033363 | 001-32639 | 251454560 | 34 | 7324104 | 1 | 1 | |
| 2025-11-03 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-032658 | 001-32639 | 251442128 | 34 | 354282 | 1 | 1 |
| 2025-09-12 | 4 | FORM 4 | 0001437749-25-028952 | 5390 | ||||||
| 2025-09-11 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-005946 | 001-32639 | 251309138 | 33 | 4601 | |||
| 2025-08-08 | S-8 | FORM S-8 | 0001437749-25-025753 | 333-289478 | 251201483 | 33 | 240439 | 1 | 1 | |
| 2025-08-08 | S-3ASR | FORM S-3ASR | 0001437749-25-025771 | 333-289454 | 251199511 | 33 | 1039385 | 1 | 1 | |
| 2025-08-08 | 10-Q | FORM 10-Q | 0001437749-25-025745 | 001-32639 | 251199060 | 34 | 6977815 | 1 | 1 | |
| 2025-08-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-024480 | 001-32639 | 251178017 | 34 | 344030 | 1 | 1 |
| 2025-06-16 | 4 | FORM 4 | 0001437749-25-020546 | 6916 | ||||||
| 2025-06-16 | 4 | FORM 4 | 0001437749-25-020545 | 4805 | ||||||
| 2025-06-16 | 4 | FORM 4 | 0001437749-25-020543 | 4773 | ||||||
| 2025-06-16 | 4 | FORM 4 | 0001437749-25-020541 | 4768 | ||||||
| 2025-06-16 | 4 | FORM 4 | 0001437749-25-020540 | 4799 | ||||||
| 2025-06-13 | 8-K | FORM 8-K | 5.07,9.01 | 0001437749-25-020335 | 001-32639 | 251047416 | 34 | 174124 | 1 | 1 |
| 2025-06-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-004055 | 001-32639 | 251045482 | 33 | 4611 | |||
| 2025-05-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000093751-25-000323 | 005-51051 | 25938581 | 34 | 8325 | |||
| 2025-05-09 | 10-Q | FORM 10-Q | 0001437749-25-015804 | 001-32639 | 25930976 | 34 | 6308814 | 1 | 1 | |
| 2025-05-05 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-014402 | 001-32639 | 25910926 | 34 | 312876 | 1 | 1 |
| 2025-04-30 | ARS | ARS | 0001437749-25-013863 | 001-32639 | 25895697 | 34 | 1858485 | |||
| 2025-04-30 | DEFA14A | FORM DEFA14A | 0001437749-25-013861 | 001-32639 | 25895665 | 34 | 247502 | |||
| 2025-04-30 | DEF 14A | FORM DEF 14A | 0001437749-25-013860 | 001-32639 | 25895651 | 34 | 2892231 | 1 | 1 | |
| 2025-04-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002013 | 005-51051 | 25893020 | 34 | 11395 | |||
| 2025-04-18 | PRE 14A | FORM PRE 14A | 0001437749-25-012371 | 001-32639 | 25850553 | 34 | 2917881 | 1 | 1 | |
| 2025-03-18 | 4 | FORM 4 | 0001437749-25-008284 | 4813 | ||||||
| 2025-03-11 | 4 | FORM 4 | 0001437749-25-007052 | 4827 | ||||||
| 2025-03-03 | 10-K | FORM 10-K | 0001437749-25-005908 | 001-32639 | 25697659 | 34 | 9508493 | 1 | 1 | |
| 2025-03-03 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-25-005802 | 001-32639 | 25693770 | 34 | 354952 | 1 | 1 |
| 2025-01-30 | 4 | FORM 4 | 0001437749-25-002292 | 5273 | ||||||
| 2025-01-30 | 4 | FORM 4 | 0001437749-25-002290 | 4846 | ||||||
| 2025-01-14 | 8-K | FORM 8-K | 7.01,9.01 | 0001437749-25-001106 | 001-32639 | 25529379 | 34 | 207633 | 1 | 1 |
| 2025-01-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000038 | 005-51051 | 25517198 | 34 | 6563 | |||
| 2025-01-07 | 4 | FORM 4 | 0001437749-25-000662 | 6577 | ||||||
| 2025-01-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000144 | 001-32639 | 25511093 | 33 | 5353 | |||
| 2025-01-03 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000097 | 001-32639 | 25507350 | 33 | 4721 | |||
| 2024-11-14 | SC 13G/A | TG THERAPEUTICS, INC | 0000902664-24-006638 | 005-51051 | 241465280 | 34 | 71443 | |||
| 2024-11-12 | 4 | FORM 4 | 0001437749-24-034597 | 4659 | ||||||
| 2024-11-12 | 4 | FORM 4 | 0001437749-24-034595 | 6769 | ||||||
| 2024-11-12 | 144/A | xsl144X01/primary_doc.xml | 0001959173-24-007724 | 001-32639 | 241446205 | 33 | 4838 | |||
| 2024-11-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-007713 | 001-32639 | 241445594 | 33 | 4649 | |||
| 2024-11-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-007703 | 001-32639 | 241445411 | 33 | 4607 | |||
| 2024-11-07 | 4 | FORM 4 | 0001437749-24-033950 | 4883 | ||||||
| 2024-11-07 | 10-Q | FORM 10-Q | 0001437749-24-033948 | 001-32639 | 241436422 | 34 | 7801176 | 1 | 1 | |
| 2024-11-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-007410 | 001-32639 | 241426795 | 33 | 5145 | |||
| 2024-11-04 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-033055 | 001-32639 | 241420748 | 34 | 335890 | 1 | 1 |
| 2024-10-07 | SC 13G/A | us88322q1085_100724.txt | 0002012383-24-000117 | 005-51051 | 241357881 | 34 | 14015 | |||
| 2024-08-09 | 10-Q | FORM 10-Q | 0001437749-24-025853 | 001-32639 | 241192503 | 34 | 8237641 | 1 | 1 | |
| 2024-08-09 | 10-K/A | FORM 10-K/A | 0001437749-24-025850 | 001-32639 | 241192457 | 34 | 341893 | 1 | 1 | |
| 2024-08-06 | 8-K | FORM 8-K | 1.01,1.02,2.02,8.01,9.01 | 0001437749-24-024718 | 001-32639 | 241177060 | 34 | 357348 | 1 | 1 |
| 2024-06-20 | 4 | FORM 4 | 0001437749-24-020851 | 7867 | ||||||
| 2024-06-20 | 4 | FORM 4 | 0001437749-24-020850 | 4775 | ||||||
| 2024-06-20 | 4 | FORM 4 | 0001437749-24-020849 | 4780 | ||||||
| 2024-06-20 | 4 | FORM 4 | 0001437749-24-020848 | 4820 | ||||||
| 2024-06-20 | 4 | FORM 4 | 0001437749-24-020847 | 4812 | ||||||
| 2024-06-20 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-004568 | 001-32639 | 241057363 | 33 | 5395 | |||
| 2024-06-20 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-004558 | 001-32639 | 241056065 | 33 | 5394 | |||
| 2024-06-17 | 8-K | FORM 8-K | 5.02,5.03,5.07,9.01 | 0001437749-24-020510 | 001-32639 | 241048941 | 34 | 219481 | 1 | 1 |
| 2024-06-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-004473 | 001-32639 | 241047898 | 33 | 4758 | |||
| 2024-06-13 | PX14A6G | tgtx24shletter.htm | 0002021815-24-000006 | 001-32639 | 241039752 | 34 | 26675 | |||
| 2024-06-10 | PX14A6G | CALSTRS FORM PX14A6G | 0000950159-24-000214 | 001-32639 | 241031864 | 34 | 34939 | |||
| 2024-05-06 | 10-Q | FORM 10-Q | 0001437749-24-014849 | 001-32639 | 24918409 | 34 | 5885371 | 1 | 1 | |
| 2024-05-01 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-014062 | 001-32639 | 24900029 | 34 | 283764 | 1 | 1 |
| 2024-04-29 | ARS | tgtx_ars.pdf | 0001437749-24-013742 | 001-32639 | 24892369 | 34 | 1017622 | |||
| 2024-04-29 | DEFA14A | FORM DEFA14A | 0001437749-24-013721 | 001-32639 | 24891669 | 34 | 755742 | |||
| 2024-04-29 | DEF 14A | FORM DEF 14A | 0001437749-24-013719 | 001-32639 | 24891544 | 34 | 3121969 | 1 | 1 | |
| 2024-04-18 | PRE 14A | FORM PRE 14A | 0001437749-24-012456 | 001-32639 | 24854889 | 34 | 2007527 | 1 | 1 | |
| 2024-03-15 | 4 | FORM 4 | 0001437749-24-008124 | 4659 | ||||||
| 2024-03-13 | 4 | FORM 4 | 0001437749-24-007662 | 5405 | ||||||
| 2024-03-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-002302 | 001-32639 | 24746011 | 33 | 4602 | |||
| 2024-03-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-002239 | 001-32639 | 24740813 | 33 | 5254 | |||
| 2024-02-29 | 10-K | FORM 10-K | 0001437749-24-006144 | 001-32639 | 24705218 | 34 | 10192286 | 1 | 1 | |
| 2024-02-28 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-24-005802 | 001-32639 | 24690164 | 34 | 337151 | 1 | 1 |
| 2024-02-14 | 5 | FORM 5 | 0001437749-24-004259 | 4894 | ||||||
| 2024-02-14 | SC 13G/A | TG THERAPEUTICS, INC. | 0000902664-24-001654 | 005-51051 | 24636843 | 34 | 77143 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-022090 | 005-51051 | 24629672 | 34 | 13359 | |||
| 2024-01-26 | SC 13G/A | us88322q1085_012624.txt | 0001086364-24-004661 | 005-51051 | 24568125 | 34 | 13941 | |||
| 2024-01-25 | SC 13G/A | TGTherapeutics.txt | 0000093751-24-000239 | 005-51051 | 24560142 | 34 | 8815 | |||
| 2024-01-10 | 8-K | FORM 8-K | 1.01,7.01,9.01 | 0001437749-24-001061 | 001-32639 | 24524876 | 34 | 215168 | 1 | 1 |
| 2024-01-08 | 4 | FORM 4 | 0001437749-24-000900 | 5646 | ||||||
| 2024-01-08 | 4 | FORM 4 | 0001437749-24-000899 | 5074 | ||||||
| 2024-01-05 | 4 | FORM 4 | 0001437749-24-000756 | 6768 | ||||||
| 2024-01-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000142 | 001-32639 | 24514954 | 33 | 4610 | |||
| 2024-01-03 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000096 | 001-32639 | 24507514 | 33 | 4564 | |||
| 2023-11-06 | 10-Q | FORM 10-Q | 0001437749-23-030412 | 001-32639 | 231380660 | 34 | 5974652 | 1 | 1 | |
| 2023-11-01 | 8-K | FORM 8-K | 2.02,9.01 | 0001437749-23-029660 | 001-32639 | 231366577 | 34 | 297913 | 1 | 1 |
| 2023-09-29 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-105403 | 5117 | ||||||
| 2023-09-29 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-105400 | 5086 | ||||||
| 2023-09-29 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-105394 | 5091 | ||||||
| 2023-09-29 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-105389 | 5131 | ||||||
| 2023-09-29 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-105383 | 5123 | ||||||
| 2023-08-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-091054 | 5665 | ||||||
| 2023-08-04 | 10-Q | 10-Q | 0001558370-23-013429 | 001-32639 | 231144460 | 34 | 6930214 | 1 | 1 | |
| 2023-08-01 | 8-K | 8-K | 1.01,2.02,9.01 | 0001558370-23-012631 | 001-32639 | 231129658 | 34 | 460593 | 1 | 1 |
| 2023-06-26 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-074784 | 5441 | ||||||
| 2023-06-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-002082 | 001-32639 | 231038050 | 33 | 4529 | |||
| 2023-06-15 | 8-K | 8-K | 5.07 | 0001558370-23-011140 | 001-32639 | 231017790 | 34 | 174320 | 1 | 1 |
| 2023-06-05 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-068182 | 5418 | ||||||
| 2023-06-02 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-001512 | 001-32639 | 23990034 | 33 | 4480 | |||
| 2023-05-08 | 10-Q | 10-Q | 0001558370-23-008385 | 001-32639 | 23895898 | 34 | 7148437 | 1 | 1 | |
| 2023-05-01 | DEFA14A | DEFA14A | 0001558370-23-007492 | 001-32639 | 23873965 | 34 | 396192 | |||
| 2023-05-01 | DEF 14A | DEF 14A | 0001558370-23-007490 | 001-32639 | 23873928 | 34 | 2140596 | 1 | 1 | |
| 2023-05-01 | 8-K | 8-K | 2.02,9.01 | 0001558370-23-007393 | 001-32639 | 23870032 | 34 | 282007 | 1 | 1 |
| 2023-04-21 | PRE 14A | PRE 14A | 0001558370-23-006442 | 001-32639 | 23836758 | 34 | 1571102 | 1 | 1 | |
| 2023-04-03 | SC 13G | TG THERAPEUTICS, INC. | 0000902664-23-002440 | 005-51051 | 23790670 | 34 | 79696 | |||
| 2023-03-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-032338 | 5158 | ||||||
| 2023-03-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-032337 | 5326 | ||||||
| 2023-03-01 | 10-K | 10-K | 0001558370-23-002610 | 001-32639 | 23695062 | 34 | 8862110 | 1 | 1 | |
| 2023-02-28 | 8-K | 8-K | 2.02,9.01 | 0001558370-23-002239 | 001-32639 | 23678390 | 34 | 345685 | 1 | 1 |
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-002127 | 005-51051 | 23605094 | 34 | 8463 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-017095 | 005-51051 | 23604424 | 34 | 13265 | |||
| 2023-02-03 | SC 13G/A | TG_Therapeutics_Inc.txt | 0000093751-23-000195 | 005-51051 | 23586163 | 34 | 10646 | |||
| 2023-02-01 | SC 13G/A | us88322q1085_020123.txt | 0001306550-23-006375 | 005-51051 | 23577521 | 34 | 13678 | |||
| 2023-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-001901 | 4942 | ||||||
| 2023-01-06 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-001900 | 5869 | ||||||
| 2022-12-28 | 8-K | 8-K | 8.01,9.01 | 0001558370-22-019019 | 001-32639 | 221494961 | 34 | 238957 | 1 | 1 |
| 2022-11-10 | 8-K | 8-K | 2.02,9.01 | 0001558370-22-017292 | 001-32639 | 221374975 | 34 | 317608 | 1 | 1 |
| 2022-11-09 | 10-Q | 10-Q | 0001558370-22-017180 | 001-32639 | 221373152 | 34 | 5866210 | 1 | 1 | |
| 2022-10-11 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-107554 | 005-51051 | 221302818 | 34 | 13266 | |||
| 2022-09-02 | S-3ASR | S-3ASR | 0001558370-22-014178 | 333-267262 | 221225570 | 33 | 1136969 | |||
| 2022-08-09 | 10-Q | 10-Q | 0001558370-22-012854 | 001-32639 | 221148078 | 34 | 5767241 | 1 | 1 | |
| 2022-08-08 | 8-K | 8-K | 2.02,9.01 | 0001558370-22-012517 | 001-32639 | 221142583 | 34 | 335965 | 1 | 1 |
| 2022-07-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-082027 | 5610 | ||||||
| 2022-07-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-082024 | 7791 | ||||||
| 2022-07-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-082023 | 5077 | ||||||
| 2022-07-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-082022 | 5046 | ||||||
| 2022-07-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-082020 | 5051 | ||||||
| 2022-07-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-082018 | 5091 | ||||||
| 2022-07-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-082016 | 5083 | ||||||
| 2022-07-11 | SC 13G/A | filing.txt | 0000315066-22-001661 | 005-51051 | 221075940 | 34 | 8094 | |||
| 2022-06-24 | S-8 | S-8 | 0001558370-22-010281 | 333-265838 | 221040883 | 33 | 166063 | |||
| 2022-06-23 | 8-K | 8-K | 5.07,9.01 | 0001558370-22-010227 | 001-32639 | 221035871 | 34 | 347079 | 1 | 1 |
| 2022-05-10 | 10-Q | 10-Q | 0001558370-22-008130 | 001-32639 | 22910217 | 34 | 5180592 | 1 | 1 | |
| 2022-04-29 | DEFA14A | DEFA14A | 0001558370-22-006485 | 001-32639 | 22875463 | 34 | 462182 | |||
| 2022-04-29 | DEF 14A | DEF 14A | 0001558370-22-006479 | 001-32639 | 22875188 | 34 | 1436840 | |||
| 2022-04-18 | 8-K | 8-K | 8.01,9.01 | 0001558370-22-005537 | 001-32639 | 22831018 | 34 | 187434 | 1 | 1 |
| 2022-03-01 | 10-K | 10-K | 0001558370-22-002617 | 001-32639 | 22699772 | 34 | 10076496 | 1 | 1 | |
| 2022-03-01 | 8-K | 8-K | 2.02,9.01 | 0001558370-22-002470 | 001-32639 | 22694093 | 34 | 311652 | 1 | 1 |
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-018707 | 005-51051 | 22611019 | 34 | 13259 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-001198 | 005-51051 | 22604604 | 34 | 8772 | |||
| 2022-02-01 | SC 13G/A | us88322q1085_020122.txt | 0000834237-22-004463 | 005-51051 | 22579885 | 34 | 13702 | |||
| 2022-01-27 | 8-K | 8-K | 8.01,9.01 | 0001558370-22-000487 | 001-32639 | 22560546 | 34 | 157656 | 1 | 1 |
| 2022-01-07 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-002361 | 7048 | ||||||
| 2022-01-07 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-002355 | 14171 | ||||||
| 2022-01-04 | 8-K | 8-K | 1.01,9.01 | 0001558370-22-000026 | 001-32639 | 22504075 | 34 | 155335 | 1 | 1 |
| 2021-11-30 | 8-K | 8-K | 8.01,9.01 | 0001558370-21-016373 | 001-32639 | 211458316 | 34 | 201076 | 1 | 1 |
| 2021-11-08 | 10-Q | 10-Q | 0001558370-21-015039 | 001-32639 | 211388161 | 34 | 6149854 | 1 | 1 | |
| 2021-11-04 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-014445 | 001-32639 | 211378004 | 34 | 347846 | 1 | 1 |
| 2021-08-06 | 10-Q | 10-Q | 0001558370-21-010837 | 001-32639 | 211153666 | 34 | 6047472 | 1 | 1 | |
| 2021-08-02 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-009752 | 001-32639 | 211134729 | 34 | 338541 | 1 | 1 |
| 2021-06-23 | 8-K | 8-K | 5.02 | 0001558370-21-008523 | 001-32639 | 211036598 | 34 | 154640 | 1 | 1 |
| 2021-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-084262 | 5313 | ||||||
| 2021-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-084261 | 5562 | ||||||
| 2021-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-084260 | 5083 | ||||||
| 2021-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-084259 | 5046 | ||||||
| 2021-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-084258 | 5051 | ||||||
| 2021-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-084257 | 5091 | ||||||
| 2021-06-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-084256 | 6749 | ||||||
| 2021-06-21 | 8-K | 8-K | 5.03,5.07,9.01 | 0001558370-21-008482 | 001-32639 | 211032079 | 34 | 194032 | 1 | 1 |
| 2021-05-10 | 10-Q | 10-Q | 0001558370-21-006712 | 001-32639 | 21908201 | 34 | 5784025 | 1 | 1 | |
| 2021-05-10 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-006573 | 001-32639 | 21905226 | 34 | 285510 | 1 | 1 |
| 2021-04-30 | DEFA14A | DEFA14A | 0001558370-21-005394 | 001-32639 | 21877720 | 34 | 370363 | |||
| 2021-04-30 | DEF 14A | DEF 14A | 0001558370-21-005391 | 001-32639 | 21877642 | 34 | 1181981 | |||
| 2021-04-20 | PRE 14A | PRE 14A | 0001558370-21-004519 | 001-32639 | 21838614 | 34 | 692930 | |||
| 2021-04-16 | 8-K | 8-K | 8.01,9.01 | 0001558370-21-004378 | 001-32639 | 21830118 | 34 | 207200 | 1 | 1 |
| 2021-04-13 | 8-K | 8-K | 4.01,9.01 | 0001558370-21-004233 | 001-32639 | 21823375 | 34 | 162166 | 1 | 1 |
| 2021-03-02 | 8-K | 8-K | 2.02,9.01 | 0001558370-21-002218 | 001-32639 | 21701269 | 34 | 337859 | 1 | 1 |
| 2021-03-01 | 10-K | 10-K | 0001558370-21-002149 | 001-32639 | 21697622 | 34 | 9257802 | 1 | 1 | |
| 2021-02-16 | SC 13G/A | greatpoint-tgtx123020a1.htm | 0001172661-21-000718 | 005-51051 | 21638544 | 34 | 77636 | |||
| 2021-02-12 | 5 | FORM 5 | 0001104659-21-022085 | 6910 | ||||||
| 2021-02-10 | SC 13G/A | SC 13G/A | 0001104659-21-019883 | 005-51051 | 21614682 | 34 | 88208 | |||
| 2021-02-10 | SC 13G/A | SC 13G/A | 0001104659-21-019852 | 005-51051 | 21614378 | 34 | 86713 | |||
| 2021-02-10 | SC 13G | SCHEDULE 13G | 0001104659-21-019225 | 005-51051 | 21612150 | 34 | 14102 | |||
| 2021-02-08 | SC 13G/A | filing.txt | 0000315066-21-001295 | 005-51051 | 21599844 | 34 | 8733 | |||
| 2021-02-08 | 8-K | 8-K | 8.01,9.01 | 0001558370-21-000791 | 001-32639 | 21598508 | 34 | 206835 | 1 | 1 |
| 2021-02-01 | SC 13G/A | us88322q1085_013121.txt | 0000834237-21-005702 | 005-51051 | 21574743 | 34 | 13712 | |||
| 2021-01-04 | 4 | OWNERSHIP DOCUMENT | 0001104659-21-000339 | 5155 | ||||||
| 2020-12-31 | 5 | OWNERSHIP DOCUMENT | 0001104659-20-140992 | 16199 | ||||||
| 2020-12-16 | 8-K | FORM 8-K | 1.01,9.01 | 0001104659-20-136290 | 001-32639 | 201392610 | 34 | 518070 | 1 | 1 |
| 2020-12-16 | 424B5 | 424B5 | 0001104659-20-136281 | 333-233636 | 201392546 | 33 | 1076876 | |||
| 2020-12-14 | 424B5 | 424B5 | 0001104659-20-135051 | 333-233636 | 201385135 | 33 | 1061031 | |||
| 2020-12-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-134811 | 5354 | ||||||
| 2020-12-10 | 8-K | 8-K | 8.01,9.01 | 0001558370-20-014296 | 001-32639 | 201379499 | 34 | 187236 | 1 | 1 |
| 2020-12-08 | 8-K | 8-K | 8.01,9.01 | 0001558370-20-014242 | 001-32639 | 201374423 | 34 | 221694 | 1 | 1 |
| 2020-11-09 | 8-K | 8-K | 2.02,9.01 | 0001558370-20-013426 | 001-32639 | 201298856 | 34 | 306657 | 1 | 1 |
| 2020-11-09 | 8-K | 8-K | 8.01,9.01 | 0001558370-20-013424 | 001-32639 | 201298821 | 34 | 197735 | 1 | 1 |
| 2020-11-09 | 424B5 | 424B5 | 0001558370-20-013420 | 333-233636 | 201298713 | 33 | 353199 | |||
| 2020-11-09 | 10-Q | 10-Q | 0001558370-20-013410 | 001-32639 | 201298624 | 34 | 7008352 | 1 | 1 | |
| 2020-11-05 | 8-K | 8-K | 8.01,9.01 | 0001558370-20-012661 | 001-32639 | 201288337 | 34 | 205677 | 1 | 1 |
| 2020-09-11 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-104436 | 10081 | ||||||
| 2020-08-10 | 10-Q | 10-Q | 0001558370-20-010225 | 001-32639 | 201090105 | 34 | 6884502 | 1 | 1 | |
| 2020-08-10 | 8-K | FORM 8-K | 2.02,9.01 | 0001104659-20-092406 | 001-32639 | 201087088 | 34 | 281817 | 1 | 1 |
| 2020-07-20 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-084949 | 6932 | ||||||
| 2020-07-02 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-080595 | 5184 | ||||||
| 2020-07-02 | 3 | OWNERSHIP DOCUMENT | 0001104659-20-080593 | 11471 | ||||||
| 2020-06-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-076547 | 5826 | ||||||
| 2020-06-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-076546 | 5041 | ||||||
| 2020-06-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-076545 | 5046 | ||||||
| 2020-06-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-076544 | 5086 | ||||||
| 2020-06-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-076543 | 5075 | ||||||
| 2020-06-24 | 4 | OWNERSHIP DOCUMENT | 0001104659-20-076542 | 7490 | ||||||
| 2020-06-24 | 8-K | 8-K | 5.02,5.07,9.01 | 0001558370-20-007744 | 001-32639 | 20986284 | 34 | 195123 | 1 | 1 |
| 2020-06-10 | SC 13G/A | SC 13G/A | 0001104659-20-072021 | 005-51051 | 20954854 | 34 | 61582 | |||
| 2020-06-10 | SC 13G | filing.txt | 0000315066-20-001583 | 005-51051 | 20953750 | 34 | 8623 | |||
| 2020-05-29 | PX14A6G | PX14A6G | 0001140361-20-012674 | 001-32639 | 20925130 | 34 | 31748 | |||
| 2020-05-18 | 8-K | 8-K | 1.01,9.01 | 0001558370-20-006811 | 001-32639 | 20890438 | 34 | 594553 | 1 | 1 |
| 2020-05-18 | 424B5 | 424B5 | 0001558370-20-006795 | 333-233636 | 20889464 | 33 | 1164747 | |||
| 2020-05-14 | 424B5 | 424B5 | 0001558370-20-006630 | 333-233636 | 20879014 | 33 | 1145058 | |||
| 2020-05-11 | 8-K | 8-K | 2.02,9.01 | 0001558370-20-006314 | 001-32639 | 20866045 | 34 | 276355 | 1 | 1 |
| 2020-05-11 | 10-Q | 10-Q | 0001558370-20-006304 | 001-32639 | 20865962 | 34 | 6361220 | 1 | 1 | |
| 2020-05-07 | 3 | OWNERSHIP DOCUMENT | 0001104659-20-058131 | 12678 | ||||||
| 2020-05-05 | 8-K | 8-K | 8.01,9.01 | 0001558370-20-005097 | 001-32639 | 20846853 | 34 | 175147 | 1 | 1 |
| 2020-04-30 | 8-K | 8-K | 5.02,9.01 | 0001558370-20-004722 | 001-32639 | 20833156 | 34 | 173027 | 1 | 1 |
| 2020-04-29 | DEFA14A | DEFA14A | 0001558370-20-004651 | 001-32639 | 20830842 | 34 | 720778 | |||
| 2020-04-29 | DEF 14A | DEF 14A | 0001558370-20-004647 | 001-32639 | 20830801 | 34 | 1006944 | |||
| 2020-03-20 | 424B5 | 424B5 | 0001558370-20-002997 | 333-233636 | 20732617 | 33 | 483390 | |||
| 2020-03-20 | 8-K | 8-K | 8.01,9.01 | 0001558370-20-002992 | 001-32639 | 20732440 | 34 | 589115 | 1 | 1 |
| 2020-03-03 | 8-K | 8-K | 2.02,9.01 | 0001558370-20-001925 | 001-32639 | 20679944 | 34 | 362073 | 1 | 1 |
| 2020-03-02 | 10-K | 10-K | 0001558370-20-001897 | 001-32639 | 20677318 | 34 | 9591482 | 1 | 1 | |
| 2020-02-14 | SC 13G/A | SC 13G/A | 0001104659-20-021910 | 005-51051 | 20620913 | 34 | 61725 | |||
| 2020-02-14 | SC 13G/A | SCHEDULE 13G HOLDINGS REPORT AMENDMENT | 0001172661-20-000786 | 005-51051 | 20619115 | 34 | 73884 | |||
| 2020-02-14 | SC 13G/A | TG THERAPEUTICS, INC. | 0000902664-20-001111 | 005-51051 | 20614899 | 34 | 57365 | |||
| 2020-02-13 | SC 13G/A | TGTherapeuticsInc.txt | 0000093751-20-000475 | 005-51051 | 20610003 | 34 | 8796 | |||
| 2020-02-07 | SC 13G | us88322q1085_020620.txt | 0000834237-20-008183 | 005-51051 | 20584818 | 34 | 13541 | |||
| 2020-01-24 | SC 13G/A | TGTX_SC13GA1.htm | 0001319244-20-000018 | 005-51051 | 20545606 | 34 | 128931 | |||
| 2020-01-02 | SC 13G | SCHEDULE 13G | 0001172661-20-000001 | 005-51051 | 20500900 | 34 | 81210 | |||
| 2019-12-26 | 8-K | 8-K | 8.01,9.01 | 0001654954-19-014209 | 001-32639 | 191308426 | 34 | 284692 | 1 | 1 |
| 2019-12-23 | 424B5 | 424B5 | 0001654954-19-014167 | 333-233636 | 191303441 | 33 | 25681 | |||
| 2019-12-09 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001654954-19-013703 | 001-32639 | 191274373 | 34 | 225279 | 1 | 1 |
| 2019-11-12 | 10-Q | 10-Q | 0001654954-19-012751 | 001-32639 | 191210965 | 34 | 5329583 | 1 | 1 | |
| 2019-11-12 | 8-K | 8-K | 2.02,9.01 | 0001654954-19-012611 | 001-32639 | 191206122 | 34 | 297268 | 1 | 1 |
| 2019-10-28 | 8-K | 8-K | 8.01,9.01 | 0001654954-19-012023 | 001-32639 | 191171170 | 34 | 176514 | 1 | 1 |
| 2019-09-18 | 4 | FORM 4 | 0001654954-19-010891 | 4798 | ||||||
| 2019-09-18 | 4 | FORM 4 | 0001654954-19-010890 | 4834 | ||||||
| 2019-09-18 | 4 | FORM 4 | 0001654954-19-010888 | 4838 | ||||||
| 2019-09-18 | 4 | FORM 4 | 0001654954-19-010886 | 4858 | ||||||
| 2019-09-18 | 4 | FORM 4 | 0001654954-19-010885 | 4791 | ||||||
| 2019-09-12 | 8-K | FORM 8-K | 8.01,9.01 | 0001654954-19-010620 | 001-32639 | 191089630 | 34 | 175904 | 1 | 1 |
| 2019-09-05 | S-3ASR | FORM S-3ASR | 0001654954-19-010402 | 333-233636 | 191077388 | 33 | 1077460 | |||
| 2019-09-05 | RW | FORM RW | 0001654954-19-010400 | 333-233565 | 191077197 | NE | 16132 | |||
| 2019-08-30 | S-3 | S-3 | 0001654954-19-010203 | 333-233565 | 191069731 | 33 | 1000211 | |||
| 2019-08-09 | 10-Q | FORM 10-Q | 0001654954-19-009176 | 001-32639 | 191013371 | 34 | 6442668 | 1 | 1 | |
| 2019-08-09 | 8-K | 8-K | 2.02,9.01 | 0001654954-19-009109 | 001-32639 | 191011314 | 34 | 161670 | ||
| 2019-07-03 | 4 | FORM4 | 0001654954-19-007935 | 5606 | ||||||
| 2019-06-27 | 4 | FORM4 | 0001654954-19-007706 | 5285 | ||||||
| 2019-06-14 | 4 | FORM4 | 0001654954-19-007359 | 5619 | ||||||
| 2019-06-13 | 8-K | 8-K | 5.07 | 0001654954-19-007297 | 001-32639 | 19896175 | 34 | 59796 | ||
| 2019-06-07 | SC 13G/A | us88322q1085_060719.txt | 0000215457-19-008047 | 005-51051 | 19886637 | 34 | 12697 | |||
| 2019-05-31 | PX14A6G | PX14A6G | 0001140361-19-010173 | 001-32639 | 19870018 | 34 | 38441 | |||
| 2019-05-10 | 10-Q | 10Q | 0001654954-19-005680 | 001-32639 | 19814766 | 34 | 3830343 | 1 | ||
| 2019-05-10 | 8-K | 8-K | 2.02,9.01 | 0001654954-19-005592 | 001-32639 | 19812800 | 34 | 115873 | ||
| 2019-05-08 | 8-K | 8-K | 8.01,9.01 | 0001654954-19-005419 | 001-32639 | 19804638 | 34 | 40866 | ||
| 2019-04-30 | DEFA14A | DEFA14A | 0001654954-19-005037 | 001-32639 | 19782356 | 34 | 396180 | |||
| 2019-04-30 | DEF 14A | DEF14A | 0001654954-19-005036 | 001-32639 | 19782278 | 34 | 861136 | |||
| 2019-04-01 | 8-K | 8-K | 8.01,9.01 | 0001654954-19-003766 | 001-32639 | 19718897 | 34 | 65707 | ||
| 2019-03-11 | SC 13G | SCHEDULE 13G HOLDINGS REPORT | 0001172661-19-000927 | 005-51051 | 19672339 | 34 | 73821 | |||
| 2019-03-07 | SC 13G | TGTX_SC13G.htm | 0001319244-19-000034 | 005-51051 | 19666639 | 34 | 97558 | |||
| 2019-03-05 | 424B5 | 424B5 | 0001654954-19-002274 | 333-218293 | 19656789 | 33 | 773615 | |||
| 2019-03-05 | 8-K | 8-K | 1.01,8.01,9.01 | 0001654954-19-002276 | 001-32639 | 19656785 | 34 | 1319755 | ||
| 2019-03-01 | 10-K | 10-K | 0001654954-19-002189 | 001-32639 | 19650197 | 34 | 5367098 | 1 | ||
| 2019-02-28 | 424B5 | 424B5 | 0001654954-19-002091 | 333-218293 | 19643107 | 33 | 602445 | |||
| 2019-02-28 | 8-K | 8-K | 8.01,9.01 | 0001654954-19-002047 | 001-32639 | 19640460 | 34 | 52676 | ||
| 2019-02-14 | SC 13G | SC 13G | 0001144204-19-008306 | 005-51051 | 19608214 | 34 | 49537 | |||
| 2019-02-14 | SC 13G/A | SCHEDULE 13G HOLDINGS REPORT AMENDMENT | 0001172661-19-000823 | 005-51051 | 19606225 | 34 | 73782 | |||
| 2019-02-14 | SC 13G | TG THERAPEUTICS, INC. | 0000093751-19-000238 | 005-51051 | 19601125 | 34 | 8840 | |||
| 2019-02-14 | SC 13G | TG THERAPEUTICS, INC. | 0000902664-19-001008 | 005-51051 | 19600953 | 34 | 62906 | |||
| 2019-02-13 | SC 13G/A | filing.txt | 0000315066-19-001380 | 005-51051 | 19595217 | 34 | 8641 | |||
| 2019-02-08 | SC 13G | us88322q1085_020719.txt | 0000215457-19-006548 | 005-51051 | 19576369 | 34 | 13541 | |||
| 2019-01-22 | 8-K | 8-K | 8.01,9.01 | 0001654954-19-000641 | 001-32639 | 19534321 | 34 | 39810 | ||
| 2019-01-03 | 4 | FORM-4 | 0001654954-19-000085 | 7535 | ||||||
| 2018-12-04 | 8-K | 8-K | 8.01,9.01 | 0001654954-18-013524 | 001-32639 | 181215394 | 34 | 58515 | ||
| 2018-11-09 | 10-Q | 10-Q | 0001654954-18-012303 | 001-32639 | 181173028 | 34 | 3372353 | 1 | ||
| 2018-11-09 | 8-K | 8-K | 2.02,9.01 | 0001654954-18-012263 | 001-32639 | 181171372 | 34 | 152970 | ||
| 2018-10-15 | 8-K | 8-K | 8.01,9.01 | 0001654954-18-011171 | 001-32639 | 181123083 | 34 | 46666 | ||
| 2018-09-25 | 8-K | 8-K | 8.01 | 0001654954-18-010436 | 001-32639 | 181084669 | 34 | 42698 | ||
| 2018-09-18 | CT ORDER | filename1.pdf | 20180917,20180918 | 9999999997-18-007926 | 001-32639 | 181073015 | 34 | 17503 | ||
| 2018-08-09 | 10-Q | 10-Q | 0001654954-18-008750 | 001-32639 | 181005528 | 34 | 3935928 | 1 | ||
| 2018-08-07 | 8-K | 8-K | 2.02,9.01 | 0001654954-18-008559 | 001-32639 | 18997985 | 34 | 153458 | ||
| 2018-07-23 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2018-07-23 09:00:00 | 9999999995-18-001856 | 333-226097 | 18965540 | 33 | 2005 | ||
| 2018-07-18 | CORRESP | filename1.htm | 0001654954-18-007816 | 13943 | ||||||
| 2018-07-17 | UPLOAD | filename1.pdf | 0000000000-18-021923 | 45000 | ||||||
| 2018-07-11 | SC 13D/A | SC 13D/A | 0001193125-18-215834 | 005-51051 | 18948105 | 34 | 149643 | |||
| 2018-07-09 | S-3 | S-3 | 0001654954-18-007460 | 333-226097 | 18945274 | 33 | 228702 | |||
| 2018-07-05 | 4 | FORM-4 | 0001654954-18-007370 | 6660 | ||||||
| 2018-07-02 | 4 | FORM-4 | 0001654954-18-007267 | 4829 | ||||||
| 2018-06-28 | 4 | FORM4 | 0001654954-18-007121 | 4796 | ||||||
| 2018-06-28 | 4 | FORM-4 | 0001654954-18-007120 | 4856 | ||||||
| 2018-06-28 | 4 | FORM-4 | 0001654954-18-007119 | 5579 | ||||||
| 2018-06-28 | 4 | FORM4 | 0001654954-18-007118 | 4790 | ||||||
| 2018-06-28 | 4 | FORM4 | 0001654954-18-007116 | 4836 | ||||||
| 2018-06-28 | 4 | FORM4 | 0001654954-18-007117 | 4813 | ||||||
| 2018-06-25 | S-8 | S-8 | 0001654954-18-006935 | 333-225868 | 18917347 | 33 | 110874 | |||
| 2018-06-20 | 8-K | 8-K | 1.01 | 0001654954-18-006777 | 001-32639 | 18908668 | 34 | 24629 | ||
| 2018-06-18 | SC 13D/A | SC 13D AMENDMENT NO. 2 | 0001193125-18-195773 | 005-51051 | 18905328 | 34 | 41093 | |||
| 2018-06-18 | 8-K | 8-K | 8.01,9.01 | 0001654954-18-006743 | 001-32639 | 18904993 | 34 | 58698 | ||
| 2018-06-18 | 4 | FORM-4 | 0001654954-18-006742 | 4710 | ||||||
| 2018-06-15 | 8-K | 8-K | 8.01,9.01 | 0001654954-18-006703 | 001-32639 | 18902572 | 34 | 63528 | ||
| 2018-06-13 | 8-K | 8-K | 5.07 | 0001654954-18-006609 | 001-32639 | 18897087 | 34 | 47971 | ||
| 2018-06-07 | 8-K | 8-K | 8.01,9.01 | 0001654954-18-006381 | 001-32639 | 18886814 | 34 | 3192289 | ||
| 2018-06-04 | 8-K | 8-K | 8.01,9.01 | 0001654954-18-006261 | 001-32639 | 18878542 | 34 | 1441632 | ||
| 2018-05-10 | 10-Q | 10-Q | 0001654954-18-005046 | 001-32639 | 18822351 | 34 | 3173646 | 1 | ||
| 2018-05-08 | 8-K | 8-K | 2.02,9.01 | 0001654954-18-004821 | 001-32639 | 18812972 | 34 | 107649 | ||
| 2018-04-30 | CT ORDER | filename1.pdf | 20180430,20180430 | 9999999997-18-005345 | 001-32639 | 18790983 | 34 | 17497 | ||
| 2018-04-30 | DEFA14A | PROXY NOTICE CARD | 0001654954-18-004521 | 001-32639 | 18789553 | 34 | 299368 | |||
| 2018-04-30 | DEF 14A | DEF14A | 0001654954-18-004519 | 001-32639 | 18789532 | 34 | 904794 | |||
| 2018-04-24 | 8-K | 8-K | 8.01,9.01 | 0001654954-18-004295 | 001-32639 | 18771757 | 34 | 42729 | ||
| 2018-03-15 | 10-K | 10-K | 0001654954-18-002638 | 001-32639 | 18693479 | 34 | 6078875 | 1 | ||
| 2018-03-08 | 8-K | 8-K | 2.02,9.01 | 0001654954-18-002262 | 001-32639 | 18675018 | 34 | 146704 | ||
| 2018-02-14 | SC 13G/A | 13G/A | 0001172661-18-000780 | 005-51051 | 18612474 | 34 | 73582 | |||
| 2018-02-13 | SC 13G/A | filing.txt | 0000315066-18-001636 | 005-51051 | 18600172 | 34 | 9691 | |||
| 2018-02-02 | 8-K | V020218_8K | 8.01 | 0001654954-18-001025 | 001-32639 | 18568853 | 34 | 42699 | ||
| 2018-01-08 | 8-K | 8-K | 1.01 | 0001654954-18-000169 | 001-32639 | 18515113 | 34 | 27625 | ||
| 2018-01-03 | 4 | FORM-4 | 0001654954-18-000068 | 7090 | ||||||
| 2017-12-11 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-011485 | 001-32639 | 171249647 | 34 | 60282 | ||
| 2017-11-09 | 10-Q | 10-Q | 0001654954-17-010322 | 001-32639 | 171191344 | 34 | 3096600 | 1 | ||
| 2017-11-08 | 8-K | 8-K | 2.02,9.01 | 0001654954-17-010173 | 001-32639 | 171185079 | 34 | 147013 | ||
| 2017-10-27 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-009767 | 001-32639 | 171159606 | 34 | 67277 | ||
| 2017-10-17 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-009506 | 001-32639 | 171141001 | 34 | 88419 | ||
| 2017-09-05 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-008143 | 001-32639 | 171069391 | 34 | 45969 | ||
| 2017-08-10 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-007238 | 001-32639 | 171021839 | 34 | 44511 | ||
| 2017-08-09 | 10-Q | 10-Q | 0001654954-17-007129 | 001-32639 | 171017891 | 34 | 3069180 | 1 | ||
| 2017-08-09 | 8-K | 8-K | 2.02,9.01 | 0001654954-17-007087 | 001-32639 | 171016461 | 34 | 154576 | ||
| 2017-08-01 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-006791 | 001-32639 | 17994965 | 34 | 46347 | 1 | 1 |
| 2017-06-21 | 8-K | 8-K | 5.07 | 0001654954-17-005749 | 001-32639 | 17922130 | 34 | 46311 | ||
| 2017-06-19 | 4 | FORM-4 | 0001654954-17-005710 | 7277 | ||||||
| 2017-06-19 | 4 | FORM4 | 0001654954-17-005708 | 4853 | ||||||
| 2017-06-19 | 4 | FORM4 | 0001654954-17-005707 | 4830 | ||||||
| 2017-06-19 | 4 | FORM4 | 0001654954-17-005706 | 4794 | ||||||
| 2017-06-19 | 4 | FORM4 | 0001654954-17-005705 | 4788 | ||||||
| 2017-06-19 | 4 | FORM4 | 0001654954-17-005704 | 4835 | ||||||
| 2017-06-19 | 4 | FORM4 | 0001654954-17-005703 | 4812 | ||||||
| 2017-06-19 | 4 | FORM4 | 0001654954-17-005702 | 6701 | ||||||
| 2017-06-16 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-005627 | 001-32639 | 17914826 | 34 | 114021 | ||
| 2017-06-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2017-06-13 11:00:00 | 9999999995-17-001522 | 333-218293 | 17910205 | 33 | 2005 | ||
| 2017-06-09 | CORRESP | filename1.htm | 0001654954-17-005480 | 12808 | ||||||
| 2017-06-09 | S-3/A | S-3 | 0001654954-17-005478 | 333-218293 | 17903129 | 33 | 415009 | |||
| 2017-06-05 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-005338 | 001-32639 | 17890073 | 34 | 94282 | ||
| 2017-05-26 | S-3 | S-3 | 0001654954-17-005148 | 333-218293 | 17874392 | 33 | 1361601 | |||
| 2017-05-24 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-005058 | 001-32639 | 17866670 | 34 | 47470 | ||
| 2017-05-10 | 10-Q | 10-Q | 0001654954-17-004345 | 001-32639 | 17830474 | 34 | 2963713 | 1 | ||
| 2017-05-05 | 8-K | 8-K | 2.02,9.01 | 0001654954-17-004080 | 001-32639 | 17816089 | 34 | 114086 | ||
| 2017-05-01 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-003837 | 001-32639 | 17801161 | 34 | 48175 | ||
| 2017-04-28 | DEF 14A | PRIMARY DOCUMENT | 0001654954-17-003773 | 001-32639 | 17795293 | 34 | 791776 | |||
| 2017-04-12 | 4 | FORM4 | 0001654954-17-003280 | 4901 | ||||||
| 2017-04-10 | SC 13G/A | filing.txt | 0000315066-17-002291 | 005-51051 | 17752104 | 34 | 9640 | |||
| 2017-04-04 | 4 | FORM4 | 0001654954-17-003070 | 4881 | ||||||
| 2017-03-21 | 10-K/A | 10-K/A | 0001654954-17-002229 | 001-32639 | 17704593 | 34 | 274271 | |||
| 2017-03-16 | 10-K | 10-K | 0001654954-17-002050 | 001-32639 | 17692383 | 34 | 5359271 | 1 | ||
| 2017-03-10 | 424B5 | 424B5 | 0001144204-17-013988 | 333-201339 | 17682190 | 33 | 633626 | |||
| 2017-03-10 | 8-K | 8-K | 8.01,9.01 | 0001654954-17-001836 | 001-32639 | 17680185 | 34 | 156667 | ||
| 2017-03-09 | 8-K | 8-K | 1.01,8.01,9.01 | 0001144204-17-013738 | 001-32639 | 17679225 | 34 | 350886 | ||
| 2017-03-08 | 424B5 | 424B5 | 0001144204-17-013451 | 333-201339 | 17675095 | 33 | 624708 | |||
| 2017-03-06 | 8-K | FORM 8-K | 8.01,9.01 | 0001654954-17-001669 | 001-32639 | 17666473 | 34 | 58161 | ||
| 2017-02-14 | SC 13G/A | SC 13G/A | 0001144204-17-009123 | 005-51051 | 17612232 | 34 | 56475 | |||
| 2017-02-14 | SC 13G/A | ja13ga2-tg_bridger.htm | 0000895345-17-000091 | 005-51051 | 17609399 | 34 | 81496 | |||
| 2017-02-14 | SC 13G/A | filing.txt | 0000315066-17-002091 | 005-51051 | 17605493 | 34 | 9648 | |||
| 2017-01-04 | 4 | PRIMARY DOCUMENT | 0001354488-17-000035 | 7095 | ||||||
| 2017-01-04 | 4 | PRIMARY DOCUMENT | 0001354488-17-000033 | 10529 | ||||||
| 2017-01-04 | 8-K | FORM 8-K | 5.02 | 0001654954-17-000064 | 001-32639 | 17506008 | 34 | 27611 | ||
| 2016-12-06 | 8-K | FORM 8-K | 8.01 | 0001654954-16-004637 | 001-32639 | 162036643 | 34 | 71090 | ||
| 2016-12-05 | 8-K | FORM 8-K | 8.01 | 0001654954-16-004586 | 001-32639 | 162034143 | 34 | 74414 | ||
| 2016-11-09 | 10-Q | 10-Q | 0001654954-16-003692 | 001-32639 | 161984162 | 34 | 3097922 | 1 | ||
| 2016-11-07 | 8-K | 8-K | 2.02,9.01 | 0001654954-16-003547 | 001-32639 | 161976582 | 34 | 165254 | ||
| 2016-10-13 | 8-K | FORM 8-K | 8.01,9.01 | 0001654954-16-002790 | 001-32639 | 161934062 | 34 | 53107 | ||
| 2016-10-04 | CT ORDER | filename1.pdf | 20161004,20161004 | 9999999997-16-026301 | 001-32639 | 161918271 | 34 | 13893 | ||
| 2016-09-01 | 4 | PRIMARY DOCUMENT | 0001354488-16-008247 | 5406 | ||||||
| 2016-08-09 | 10-Q | 10-Q | 0001654954-16-001302 | 001-32639 | 161817797 | 34 | 3382190 | 1 | ||
| 2016-08-08 | 8-K | PRIMARY DOCUMENT | 2.02,9.01 | 0001654954-16-001249 | 001-32639 | 161812511 | 34 | 154652 | ||
| 2016-07-08 | 4 | OWNERSHIP DOCUMENT | 0001144204-16-112317 | 5029 | ||||||
| 2016-07-08 | 4 | OWNERSHIP DOCUMENT | 0001144204-16-112316 | 5470 |
One latest value per concept from companyfacts (474 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 151.15M | 2026-11-04 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 2.50B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 616.30M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014233 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 3.41M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014233 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 3.77M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014233 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 120 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014233 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 28.30M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014233 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 25.57M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014233 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 57 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001437749-26-014233 | ||
| us-gaap | AccountsAndOtherReceivablesNetCurrent | Accounts and Other Receivables, Net, Current | USD | 152,000 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-24 | 0001144204-14-044721 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 176.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 1.80M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001144204-12-062637 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 416.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.87B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 60.69M | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | USD | 2.25M | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 19,210 | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 188,509 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001144204-12-062637 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 12.33M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 800,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 595,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | AdministrativeFeesExpense | Administrative Fees Expense | USD | 367,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 64.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 779,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 800,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 159,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-06 | 0001437749-23-030412 |
| us-gaap | AmortizationOfLeaseIncentives | Amortization of Lease Incentives | USD | 106,000 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-06 | 0001558370-21-010837 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 15.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 2.80M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-15 | 0001144204-16-088155 |
| us-gaap | Assets | Assets | USD | 1.59B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 1.17B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 3.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | AvailableForSaleSecuritiesEquitySecurities | Available-for-sale Securities, Equity Securities | USD | 175.00M | 2015-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001654954-18-002638 | |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityPurchasePrice | Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) | USD | 378,238 | 2011-12-29 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityTransactionCosts | Business Acquisition, Transaction Costs | USD | 231,580 | 2011-12-29 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued | Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares | 281,250 | 2011-11-29 | 2011-12-29 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationAssetsAcquired | Business Acquisition, Purchase Price Allocation, Assets Acquired (Deprecated 2013-01-31) | USD | 4.00M | 2011-12-29 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet | Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net (Deprecated 2013-01-31) | USD | 378,238 | 2011-12-29 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents | Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents (Deprecated 2013-01-31) | USD | 10,386 | 2011-12-29 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationGoodwillAmount | Business Acquisition, Purchase Price Allocation, Goodwill Amount (Deprecated 2013-01-31) | USD | 799,391 | 2011-12-29 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill | Business Acquisition, Purchase Price Allocation, Intangible Assets Other than Goodwill (Deprecated 2013-01-31) | USD | 3.90M | 2011-12-29 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed | Business Acquisition, Purchase Price Allocation, Liabilities Assumed (Deprecated 2013-01-31) | USD | 4.42M | 2011-12-29 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationOtherAssets | Business Acquisition, Purchase Price Allocation, Other Assets (Deprecated 2013-01-31) | USD | 90,770 | 2011-12-29 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | BusinessAcquisitionsProFormaNetIncomeLoss | Business Acquisition, Pro Forma Net Income (Loss) | USD | -818,279 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 |
| us-gaap | BusinessAcquisitionsProFormaRevenue | Business Acquisition, Pro Forma Revenue | USD | 0 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 |
| us-gaap | Cash | Cash | USD | 399.88M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 | |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 10,386 | 2011-12-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001144204-14-030472 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 429.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 2.72M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 556.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 430.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 430.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 350.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | USD/Warrant | 2.25 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 100 | 2014-07-18 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight | Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares | 1 | 2014-07-18 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 0.001 | 2014-07-18 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 147,058 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 | |
| us-gaap | ClearingFeesRevenue | Clearing Fees Revenue (Deprecated 2018-01-31) | USD | 38,095 | 2017-10-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001654954-18-002638 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 190.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 160.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 151.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 160,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | ConstructionContractCostProgressPaymentOffset | Construction Contract Cost, Progress Payment Offset | USD | 37.40M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 | |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 115.43M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | ContractualObligationDueAfterFifthYear | Contractual Obligation, to be Paid, after Year Five | USD | 4.71M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | ContractualObligationDueInFourthAndFifthYear | Contractual Obligation, to be Paid, Year Four and Five | USD | 3.74M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 2.39M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | ContractualObligationDueInSecondAndThirdYear | Contractual Obligation, to be Paid, Year Two and Three | USD | 104.58M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 26.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 7.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 4.38M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001144204-12-062637 | |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 4.38M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001144204-12-062637 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 0 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001144204-12-062637 | |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 8.89 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 116.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 139,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001558370-21-006712 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 562.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | CostsAndExpensesRelatedParty | Costs and Expenses, Related Party | USD | 1.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 8.21M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 8.21M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 595,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 106.37M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-09 | 0001437749-24-025853 | |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 1,125 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-10 | 0001144204-16-100475 | |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 95.00M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-09 | 0001437749-24-025853 | |
| us-gaap | DebtInstrumentFairValue | Debt Instrument, Fair Value Disclosure | USD | 3.29M | 2011-12-31 | 2014 | FY | 10-K | 2015-03-16 | 0001144204-15-016369 | |
| us-gaap | DebtInstrumentInterestRateDuringPeriod | Debt Instrument, Interest Rate During Period | pure | 0.05 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-10 | 0001144204-16-100475 |
| us-gaap | DebtInstrumentInterestRateEffectivePercentage | Debt Instrument, Interest Rate, Effective Percentage | pure | 0.05 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-16 | 0001144204-15-016369 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.09 | 2023-03-31 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 | |
| us-gaap | DebtInstrumentRepaidPrincipal | DebtInstrumentRepaidPrincipal | USD | 0 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-09 | 0001437749-24-025853 |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | 4.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001437749-24-033948 |
| us-gaap | DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss | DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss | USD | 127.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | DeferredCompensationLiabilityCurrent | Deferred Compensation Liability, Current | USD | 54.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | -335.08M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | DeferredFinanceCostsCurrentNet | Debt Issuance Costs, Current, Net | USD | 0 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 | |
| us-gaap | DeferredFinanceCostsGross | Debt Issuance Costs, Gross | USD | 4.90M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001437749-26-015246 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 333.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 14.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | DeferredRentCredit | Deferred Rent Credit | USD | 800,000 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001654954-16-003692 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001558370-20-001897 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 300,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 16.82M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025955 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 14.53M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025955 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | -12.92M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | DeferredTaxAssetInterestCarryforward | Deferred Tax Asset, Interest Carryforward | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001437749-25-005908 | |
| us-gaap | DeferredTaxAssetsCapitalLossCarryforwards | Deferred Tax Assets, Capital Loss Carryforwards | USD | 39.41M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 391.87M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-15 | 0001144204-16-088155 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 348.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 275.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 27.97M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsForeign | Deferred Tax Assets, Tax Credit Carryforwards, Foreign | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-15 | 0001144204-16-088155 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 58.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 15.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 39.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 3.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | Depreciation | Depreciation | USD | 173,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-06 | 0001437749-23-030412 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 158,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 538,830 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 | |
| us-gaap | DevelopmentStageEnterpriseCumulativeRevenue | Development Stage Enterprise, Cumulative Revenue (Deprecated 2012-01-31) | USD | 0 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 46.95M | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001144204-14-030472 | |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 1.18M | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | DividendsPreferredStockStock | Dividends, Preferred Stock, Stock | USD | 759,134 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 0.58 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -2.63 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001558370-22-002617 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | 0.52 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.205 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.076 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.014 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.06 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.068 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount | Share-based Payment Arrangement, Amount Capitalized | USD | 1.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 15.30M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001558370-20-001897 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 0 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001144204-14-068736 | |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 0.13 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 | |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 8.48M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | EquitySecuritiesFvNiCurrentAndNoncurrent | EquitySecuritiesFvNiCurrentAndNoncurrent | USD | 3.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | EquitySecuritiesFvNiUnrealizedGainLoss | Equity Securities, FV-NI, Unrealized Gain (Loss) | USD | 2.76M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025955 |
| us-gaap | ExtinguishmentOfDebtGainLossNetOfTax | Extinguishment of Debt, Gain (Loss), Net of Tax | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001654954-17-002050 |
| us-gaap | FairValueInputsDiscountRate | Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) | pure | 0.2 | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 3.29M | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) | USD | -24,000 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 505,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 | |
| us-gaap | FinancingInterestExpense | Financing Interest Expense | USD | 2.80M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 |
| us-gaap | GainLossOnDerivativeInstrumentsNetPretax | Gain (Loss) on Derivative Instruments, Net, Pretax | USD | -2.46M | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | GainLossOnDispositionOfIntangibleAssets | Gain (Loss) on Disposition of Intangible Assets | USD | -1.21M | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 |
| us-gaap | GainLossOnSaleOfSecuritiesNet | Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) | USD | 0 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-09 | 0001654954-17-010322 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -9.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 107.85M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 |
| us-gaap | Goodwill | Goodwill | USD | 799,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-06 | 0001437749-24-014849 | |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 |
| us-gaap | GrantsReceivableCurrent | Grants Receivable, Current | USD | 0 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 | |
| us-gaap | HeldToMaturitySecurities | Debt Securities, Held-to-maturity | USD | 47.90M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 | |
| us-gaap | HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain | Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss | Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss | USD | 845,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | HeldToMaturitySecuritiesFairValue | Debt Securities, Held-to-maturity, Fair Value | USD | 126.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | HeldToMaturitySecuritiesUnrecognizedHoldingGains | Held-to-maturity Securities, Unrecognized Holding Gain (Deprecated 2018-01-31) | USD | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001654954-18-005046 |
| us-gaap | HeldToMaturitySecuritiesUnrecognizedHoldingLosses | Held-to-maturity Securities, Unrecognized Holding Loss (Deprecated 2018-01-31) | USD | 39,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001654954-18-005046 |
| us-gaap | ImpairmentOfIntangibleAssetsExcludingGoodwill | Impairment of Intangible Assets (Excluding Goodwill) | USD | 1.25M | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | 107.74M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 104.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -349,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -279.38M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | -750,000 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 17.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 21.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperations | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) | USD | -8.79M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems | Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations | USD | -41.65M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeTaxPaidForeignAfterRefundReceived | IncomeTaxPaidForeignAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -3.77M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | -4.97M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | 22.55M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 324,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | -8.12M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 1.46M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeTaxReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | USD | -3.51M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -6.44M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001654954-17-002050 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 7.35M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 68.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 111.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | -10.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncreaseDecreaseInAccruedInterestReceivableNet | Increase (Decrease) in Accrued Interest Receivable, Net | USD | 6,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 |
| us-gaap | IncreaseDecreaseInDeferredCharges | Increase (Decrease) in Deferred Charges | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001558370-20-001897 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 3.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncreaseDecreaseInEquitySecuritiesFvNi | Increase (Decrease) in Equity Securities, FV-NI | USD | 1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | -43,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 70.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | -2.37M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-06 | 0001437749-23-030412 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | -1.19M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | -9.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | -1.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001558370-20-001897 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 25,511 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -11,740 | 2011-04-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-14 | 0001144204-12-028735 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | 2.23M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 |
| us-gaap | IncreaseDecreaseInPrepaidRent | Increase (Decrease) in Prepaid Rent | USD | 91,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-09 | 0001654954-19-009176 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 4,083 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001654954-18-002638 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | -7.61M | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | InterestExpense | Interest Expense | USD | 2.29M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-06 | 0001437749-24-014849 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 40.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 1.85M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-09 | 0001654954-19-009176 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 68,387 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 35.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-16 | 0001144204-15-016369 | |
| us-gaap | InterestPayableCurrentAndNoncurrent | Interest Payable | USD | 190,017 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-16 | 0001144204-15-016369 | |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 95,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 2.00M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | InventoryFinishedGoodsAndWorkInProcessNetOfReserves | Inventory, Finished Goods and Work in Process, Net of Reserves | USD | 21.09M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001437749-25-033363 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 194.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | InventoryNoncurrent | Inventory, Noncurrent | USD | 20.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 6.58M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 4.06M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001437749-25-033363 | |
| us-gaap | InventoryValuationReserves | Inventory Valuation Reserves | USD | 6.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 31.24M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 121.81M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001437749-25-033363 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | InvestmentIncomeAmortizationOfDiscount | Investment Income, Amortization of Discount | USD | 331,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 |
| us-gaap | InvestmentIncomeAmortizationOfPremium | Investment Income, Amortization of Premium | USD | 517,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 46,609 | 2011-12-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 835,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 1.00M | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001654954-16-003692 |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 10.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive | Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five | USD | 12.06M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 2.89M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001437749-25-005908 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five | USD | 1.58M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four | USD | 1.59M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three | USD | 1.56M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two | USD | 1.55M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months | USD | 393,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.83M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001437749-25-005908 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 2.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 2.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 530,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 2.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | Liabilities | Liabilities | USD | 1.02B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.59B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 260.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 1.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LicensesRevenue | Licenses Revenue (Deprecated 2018-01-31) | USD | 38,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001654954-18-005046 |
| us-gaap | LoansPayable | Loans Payable | USD | 102.54M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-09 | 0001437749-24-025853 | |
| us-gaap | LoansPayableCurrent | Loans Payable, Current | USD | 0 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-09 | 0001437749-24-025853 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 100.40M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-06 | 0001437749-23-030412 | |
| us-gaap | LongTermDebtMaturingInYearsFourAndFive | Long-Term Debt, Maturity, Year Four and Five | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | LongTermDebtMaturingInYearsTwoAndThree | Long-Term Debt, Maturity, Year Two and Three | USD | 100.40M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive | Long-Term Debt, Maturity, after Year Five | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 745.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 56.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | LongTermLoansPayable | Loans Payable, Noncurrent | USD | 102.54M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-09 | 0001437749-24-025853 | |
| us-gaap | LongTermNotesPayable | Notes Payable, Noncurrent | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 | |
| us-gaap | LossContingencyDamagesSoughtValue | Loss Contingency, Damages Sought, Value | USD | 7.00M | 2011-04-01 | 2011-04-19 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 |
| us-gaap | MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 76,032 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | MarketableSecuritiesRealizedGainLoss | Marketable Securities, Realized Gain (Loss) | USD | -76,032 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | MinorityInterest | Stockholders' Equity Attributable to Noncontrolling Interest | USD | 0 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | MoneyMarketFundsAtCarryingValue | Money Market Funds, at Carrying Value | USD | 153.56M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 291.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 105.86M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -7.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -722,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 66.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -102.41M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 83.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | -8.15M | 2011-12-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001144204-14-030472 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -61.01M | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | NoninterestExpenseOfferingCost | Noninterest Expense Offering Cost | USD | 60,000 | 2019-01-01 | 2019-06-30 | 2020 | Q2 | 10-Q | 2020-08-10 | 0001558370-20-010225 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -37.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | NotesIssued1 | Notes Issued | USD | 15.50M | 2010-03-01 | 2010-03-31 | 2016 | Q1 | 10-Q | 2016-05-10 | 0001144204-16-100475 |
| us-gaap | NotesPayable | Notes Payable | USD | 938,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 938,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 | |
| us-gaap | NotesPayableFairValueDisclosure | Notes Payable, Fair Value Disclosure | USD | 1.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | pure | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 105.54M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | 142.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 2.20M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0001437749-24-006144 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 8.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 6.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | OperatingLeasePaymentsUse | Operating Lease, Payments, Use | USD | 800,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025955 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 6.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 35.35M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.36M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears | Operating Leases, Future Minimum Payments, Due in Four and Five Years | USD | 2.74M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears | Operating Leases, Future Minimum Payments, Due in Two and Three Years | USD | 21.05M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 10.19M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 2.70M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001558370-20-001897 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.084 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 1.30B | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001558370-22-002617 | |
| us-gaap | OtherAccountsPayableAndAccruedLiabilities | Other Accounts Payable and Accrued Liabilities | USD | 4.76M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 55.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 2.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 41.52M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 |
| us-gaap | OtherIncome | Other Income | USD | 1.29M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 |
| us-gaap | OtherInventoryCapitalizedCosts | Other Inventory, Capitalized Costs, Gross | USD | 1.15M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 1.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-02 | 0001558370-20-001897 | |
| us-gaap | OtherLongTermDebt | Other Long-term Debt | USD | 95.00M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 | |
| us-gaap | OtherLongTermNotesPayable | Other Notes Payable, Noncurrent | USD | 0 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001144204-12-062637 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -23,917 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 11.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | OtherNotesPayable | Other Notes Payable | USD | 677,778 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001144204-12-062637 | |
| us-gaap | OtherNotesPayableCurrent | Other Notes Payable, Current | USD | 677,778 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001144204-12-062637 | |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 174.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | OtherSellingGeneralAndAdministrativeExpense | Other Selling, General and Administrative Expense | USD | 198.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 480,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 |
| us-gaap | PaymentsForProceedsFromInvestments | Payments for (Proceeds from) Investments | USD | 23.13M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 |
| us-gaap | PaymentsForProceedsFromShortTermInvestments | Payments for (Proceeds from) Short-term Investments | USD | -435,938 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-15 | 0001144204-16-088155 |
| us-gaap | PaymentsForRepurchaseOfEquity | Payments for Repurchase of Equity | USD | 199.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 2.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 1.31M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-15 | 0001144204-16-088155 |
| us-gaap | PaymentsToAcquireEquitySecuritiesFvNi | PaymentsToAcquireEquitySecuritiesFvNi | USD | 1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | PaymentsToAcquireHeldToMaturitySecurities | Payments to Acquire Held-to-maturity Securities | USD | 49.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 23.13M | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001558370-20-013410 |
| us-gaap | PaymentsToAcquireLeaseReceivables | Payments to Acquire Lease Receivables | USD | 80,000 | 2014-09-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001144204-14-068736 |
| us-gaap | PaymentsToAcquireLongtermInvestments | Payments to Acquire Long-term Investments | USD | 1.25M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-09 | 0001437749-25-015804 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 626,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | PreferredStockLiquidationPreference | Preferred Stock, Liquidation Preference Per Share | USD/shares | 20 | 2012-02-24 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 | |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 0 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001558370-21-006712 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001558370-21-006712 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001558370-21-006712 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 0 | 2015-12-31 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001654954-16-003692 | |
| us-gaap | ProceedsFromDivestitureOfInterestInJointVenture | Proceeds from Divestiture of Interest in Joint Venture | USD | 3.20M | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | ProceedsFromFeesReceived | Proceeds from Fees Received | USD | 2.00M | 2016-01-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-09 | 0001654954-16-001302 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 53.64M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 747.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 12.26M | 2011-12-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-14 | 0001144204-14-030472 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 13.91M | 2012-02-01 | 2012-02-24 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 150,000 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities | USD | 44.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | Proceeds from Maturities, Prepayments and Calls of Short-term Investments | USD | 80.40M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-09 | 0001437749-25-015804 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 1.51M | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | ProceedsFromOtherDebt | Proceeds from Other Debt | USD | 25.00M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-06 | 0001437749-23-030412 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | 373,433 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | ProceedsFromRepaymentsOfSecuredDebt | Proceeds from (Repayments of) Secured Debt | USD | -255.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities | Proceeds from Sale and Maturity of Held-to-maturity Securities | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 |
| us-gaap | ProceedsFromSaleOfHeldToMaturitySecurities | Proceeds from Sale of Held-to-maturity Securities | USD | 3.85M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001144204-15-029311 |
| us-gaap | ProceedsFromSaleOfIntangibleAssets | Proceeds from Sale of Intangible Assets | USD | 200,001 | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 1.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 1.11M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -86.84M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 66,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-06 | 0001437749-24-014849 | |
| us-gaap | PurchaseObligation | Purchase Obligation | USD | 219.80M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025955 | |
| us-gaap | PurchaseObligationDueInNextTwelveMonths | Purchase Obligation, to be Paid, Year One | USD | 105.70M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025955 | |
| us-gaap | PurchaseObligationDueInSecondYear | Purchase Obligation, to be Paid, Year Two | USD | 114.10M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025955 | |
| us-gaap | PurchaseObligationDueInThirdYear | Purchase Obligation, to be Paid, Year Three | USD | 92.70M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001437749-26-015246 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 39.32M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-06 | 0001437749-23-030412 | |
| us-gaap | RecognitionOfDeferredRevenue | Recognition of Deferred Revenue | USD | 100,800 | 2004-01-01 | 2004-12-31 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-21 | 0001144204-13-016691 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001654954-17-002050 |
| us-gaap | RepaymentsOfShortTermDebt | Repayments of Short-term Debt | USD | 200,001 | 2011-12-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 195.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 11.89M | 2001-08-06 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 1.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 1.25M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 | |
| us-gaap | RestrictedCashAndInvestments | Restricted Cash and Investments | USD | 1.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 1.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | RestrictedStockExpense | Restricted Stock or Unit Expense | USD | 16.05M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001558370-21-006712 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -998.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 705.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | RevenueRecognitionSalesReturnsReserveForSalesReturns | Revenue Recognition, Sales Returns, Reserve for Sales Returns | USD | 600,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 |
| us-gaap | Revenues | Revenues | USD | 2.79M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 1.47M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-06 | 0001437749-23-030412 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 27.50M | 2019-03-01 | 2021 | FY | 10-K | 2022-03-01 | 0001558370-22-002617 | |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 5.43M | 2019-12-22 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 | |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 9.2 | 2019-12-22 | 2020 | FY | 10-K | 2021-03-01 | 0001558370-21-002149 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 251.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 72.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | USD | 3.34B | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001558370-20-013410 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | -106,046 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-09 | 0001654954-19-009176 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 7.82 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-09 | 0001654954-19-009176 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 1.27M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-09 | 0001654954-19-009176 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 12.95 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-09 | 0001654954-19-009176 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 1.09M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001558370-22-002617 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 7.76 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-09 | 0001654954-19-009176 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | -620,527 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-09 | 0001654954-19-009176 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 8.91 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-09 | 0001654954-19-009176 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001437749-25-005908 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.897 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001437749-25-005908 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.884 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001437749-25-005908 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.034 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001437749-25-005908 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.03 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001437749-25-005908 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | shares | 0 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001558370-20-013410 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations | shares | 0 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001558370-20-013410 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares | 0 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001558370-20-013410 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | shares | 147,058 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001558370-20-013410 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 28,026 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001558370-20-006304 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 82.11M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 3.57M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 6.78 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 56,250 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 2.98M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 96.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 4.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 6.82 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 1.85B | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 2.54M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 6.63 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 25,080 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001144204-14-068736 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 4,194 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001144204-14-068736 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 49.14 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001144204-14-068736 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 7.22 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 12.08 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 |
| us-gaap | ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity | Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity | USD | 20,000 | 2007-01-01 | 2007-12-31 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | SharePrice | Share Price | USD/shares | 5.87 | 2019-03-01 | 2021 | FY | 10-K | 2022-03-01 | 0001558370-22-002617 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 75.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 572.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 40.45M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001558370-23-013429 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio | Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) | pure | -56.25 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001144204-12-062637 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForCash | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) | shares | 2.20M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001144204-15-029311 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 4.10M | 2019-03-01 | 2021 | FY | 10-K | 2022-03-01 | 0001558370-22-002617 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 180,660 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 11.05M | 2005-01-01 | 2005-12-31 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 33,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-01 | 0001654954-19-002189 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForCash | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | USD | 34.80M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001144204-15-029311 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 5.35M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001654954-17-002050 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 46.30M | 2023-04-01 | 2023-06-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001437749-24-033948 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 322,964 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-07 | 0001144204-14-014207 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Forfeitures | USD | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 252,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | StockOptionPlanExpense | Stock or Unit Option Plan Expense | USD | 568,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001558370-21-006712 |
| us-gaap | StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 | Stock Repurchase Program, Remaining Authorized Repurchase Amount | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001437749-26-006133 | |
| us-gaap | TradingSecuritiesUnrealizedHoldingGain | Trading Securities, Unrealized Holding Gain | USD | 35,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 |
| us-gaap | TradingSecuritiesUnrealizedHoldingLoss | Trading Securities, Unrealized Holding Loss | USD | 3,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001654954-19-012751 |
| us-gaap | TreasuryStockAcquiredAverageCostPerShare | Treasury Stock Acquired, Average Cost Per Share | USD/shares | 28.55 | 2024-08-02 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025955 |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 8.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | TreasuryStockCommonValue | Treasury Stock, Common, Value | USD | 300.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | TreasuryStockShares | Treasury Stock, Shares | shares | 41,309 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001558370-23-002610 | |
| us-gaap | TreasuryStockSharesAcquired | Treasury Stock, Shares, Acquired | shares | 3.50M | 2024-08-02 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001437749-26-025955 |
| us-gaap | TreasuryStockValue | Treasury Stock, Value | USD | 300.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | TreasuryStockValueAcquiredCostMethod | Treasury Stock, Value, Acquired, Cost Method | USD | 100.00M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | UnamortizedDebtIssuanceExpense | Unamortized Debt Issuance Expense | USD | 3.83M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-09 | 0001437749-24-025853 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -987 | 2006-01-01 | 2006-12-31 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001437749-25-005908 | |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-03 | 0001437749-25-005908 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | -371.70M | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 | |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 0 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001144204-11-063558 | |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 15.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 157.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 132.22M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001558370-22-002617 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 142.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001628280-26-072257 |
| us-gaap | WeightedAverageNumberOfSharesRestrictedStock | Weighted Average Number of Shares, Restricted Stock | shares | 110,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001654954-18-005046 |